US equities |
NVDA $237.60 ▲+1.56% SPCX $168.58 ▲+6.05% MU $1,062.00 ▼-1.20% TSLA $379.78 ▲+2.48% MSFT $524.86 ▲+1.42% SNDK $1,715.66 ▼-0.25% INTC $117.05 ▼-1.91% META $743.10 ▲+2.06%
FinancialContent

Latest News about SGLT2

Recent news which mentions SGLT2

2023 HFSA CME Symposium - Improving Outcomes with SGLT2 Inhibitors in Patients with Heart Failure: From Evidence to Clinical Practice
Tags Medical Heartfailure Event
From PRLog
2023 ANNA CE Symposium- Newer Therapies to Optimize Outcomes in Patients with Chronic Kidney Disease
Tags ANNA23 Ckd Nephrology
From PRLog
CME Symposium- Bridging the Gap Between Evidence and Clinical Practice: Improving Outcomes with #SGLT2Inhibitors in Patients with #HeartFailure
Tickers CME
Tags New Jersey Education United States
From PRLog